NEW YORK ( TheStreet) -- Shares of Regeneron Pharmaceuticals (Nasdaq: REGN) were gapping up Wednesday morning with an open price 11.3% higher than Tuesday's closing price. The stock closed at $121.44 Tuesday and opened today's trading at $135.13.
The average volume for Regeneron has been 926,300 shares per day over the past 30 days. Regeneron has a market cap of $11.32 billion and is part of the health care sector and drugs industry. Shares are up 119.1% year to date as of the close of trading on Tuesday. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of serious medical conditions in the United States. TheStreet Ratings rates Regeneron as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow, poor profit margins and disappointing return on equity. You can view the full Regeneron Ratings Report. Get more investment ideas from our investment research center.